Skip to main content
Erschienen in: Lung 2/2011

01.04.2011

Aspergillus Lung Disease in Patients with Sarcoidosis: A Case Series and Review of the Literature

verfasst von: Tahuanty A. Pena, Ayman O. Soubani, Lobelia Samavati

Erschienen in: Lung | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Chronic cavitary pulmonary aspergillosis (CCPA) has been associated with advanced lung diseases. Pulmonary sarcoidosis, a granulomatous inflammatory disorder, is associated with CCPA. We identified CCPA in 2% of cases in a large cohort of sarcoidosis patients. We found a lack of response to medical treatment and poor outcome in this subgroup.
Literatur
1.
Zurück zum Zitat Walsh TJ, Anaissie EJ, Denning DW et al (2008) Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46(3):327–360PubMedCrossRef Walsh TJ, Anaissie EJ, Denning DW et al (2008) Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46(3):327–360PubMedCrossRef
2.
Zurück zum Zitat Denning DW, Riniotis K, Dobrashian R et al (2003) Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review. Clin Infect Dis 37(Suppl 3):S265–S280PubMedCrossRef Denning DW, Riniotis K, Dobrashian R et al (2003) Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review. Clin Infect Dis 37(Suppl 3):S265–S280PubMedCrossRef
3.
Zurück zum Zitat Wollschlager C, Khan F (1984) Aspergillomas complicating sarcoidosis. A prospective study in 100 patients. Chest 86(4):585–588PubMedCrossRef Wollschlager C, Khan F (1984) Aspergillomas complicating sarcoidosis. A prospective study in 100 patients. Chest 86(4):585–588PubMedCrossRef
4.
Zurück zum Zitat [No authors listed] (1999) Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 160(2):736–755 [No authors listed] (1999) Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 160(2):736–755
5.
Zurück zum Zitat Marzouk K, Saleh S, Kannass M et al (2004) Interferon-induced granulomatous lung disease. Curr Opin Pulm Med 10(5):435–440PubMedCrossRef Marzouk K, Saleh S, Kannass M et al (2004) Interferon-induced granulomatous lung disease. Curr Opin Pulm Med 10(5):435–440PubMedCrossRef
6.
Zurück zum Zitat Girard N, Cottin V, Hot A et al (2004) Opportunistic infections and sarcoidosis. Rev Mal Respir 21(6 Pt 1):1083–1090PubMed Girard N, Cottin V, Hot A et al (2004) Opportunistic infections and sarcoidosis. Rev Mal Respir 21(6 Pt 1):1083–1090PubMed
7.
Zurück zum Zitat Baughman RP, Lower EE (2005) Fungal infections as a complication of therapy for sarcoidosis. QJM 98(6):451–456PubMedCrossRef Baughman RP, Lower EE (2005) Fungal infections as a complication of therapy for sarcoidosis. QJM 98(6):451–456PubMedCrossRef
8.
Zurück zum Zitat Lachkar S, Dominique S, Thiberville L et al (2007) Aspergillosis and sarcoidosis. Rev Mal Respir 24(8):943–953PubMed Lachkar S, Dominique S, Thiberville L et al (2007) Aspergillosis and sarcoidosis. Rev Mal Respir 24(8):943–953PubMed
9.
Zurück zum Zitat De Pauw B, Walsh TJ, Donnelly JP et al (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46(12):1813–1821PubMedCrossRef De Pauw B, Walsh TJ, Donnelly JP et al (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46(12):1813–1821PubMedCrossRef
10.
Zurück zum Zitat Samarakoon P, Soubani AO (2008) Invasive pulmonary aspergillosis in patients with COPD: a report of five cases and systematic review of the literature. Chron Respir Dis 5(1):19–27PubMedCrossRef Samarakoon P, Soubani AO (2008) Invasive pulmonary aspergillosis in patients with COPD: a report of five cases and systematic review of the literature. Chron Respir Dis 5(1):19–27PubMedCrossRef
11.
Zurück zum Zitat Muller NL, Kullnig P, Miller RR (1989) The CT findings of pulmonary sarcoidosis: analysis of 25 patients. AJR Am J Roentgenol 152(6):1179–1182PubMed Muller NL, Kullnig P, Miller RR (1989) The CT findings of pulmonary sarcoidosis: analysis of 25 patients. AJR Am J Roentgenol 152(6):1179–1182PubMed
12.
Zurück zum Zitat Glimp RA, Bayer AS (1983) Pulmonary aspergilloma. Diagnostic and therapeutic considerations. Arch Intern Med 143(2):303–308PubMedCrossRef Glimp RA, Bayer AS (1983) Pulmonary aspergilloma. Diagnostic and therapeutic considerations. Arch Intern Med 143(2):303–308PubMedCrossRef
13.
Zurück zum Zitat Hance AJ, Basset F, Saumon G et al (1986) Smoking and interstitial lung disease. The effect of cigarette smoking on the incidence of pulmonary histiocytosis X and sarcoidosis. Ann N Y Acad Sci 465:643–656PubMedCrossRef Hance AJ, Basset F, Saumon G et al (1986) Smoking and interstitial lung disease. The effect of cigarette smoking on the incidence of pulmonary histiocytosis X and sarcoidosis. Ann N Y Acad Sci 465:643–656PubMedCrossRef
14.
Zurück zum Zitat Valeyre D, Soler P, Clerici C et al (1988) Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease. Thorax 43(7):516–524PubMedCrossRef Valeyre D, Soler P, Clerici C et al (1988) Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease. Thorax 43(7):516–524PubMedCrossRef
15.
Zurück zum Zitat Hanley ME, King TE Jr, Schwarz MI et al (1991) The impact of smoking on mechanical properties of the lungs in idiopathic pulmonary fibrosis and sarcoidosis. Am Rev Respir Dis 144(5):1102–1106PubMed Hanley ME, King TE Jr, Schwarz MI et al (1991) The impact of smoking on mechanical properties of the lungs in idiopathic pulmonary fibrosis and sarcoidosis. Am Rev Respir Dis 144(5):1102–1106PubMed
16.
Zurück zum Zitat Peros-Golubicic T, Ljubic S (1995) Cigarette smoking and sarcoidosis. Acta Med Croatica 49(4–5):187–193PubMed Peros-Golubicic T, Ljubic S (1995) Cigarette smoking and sarcoidosis. Acta Med Croatica 49(4–5):187–193PubMed
17.
Zurück zum Zitat Pfeifer AK, Lange P (2006) Pulmonary consequences of marijuana smoking. Ugeskr Laeger 168(18):1743–1746PubMed Pfeifer AK, Lange P (2006) Pulmonary consequences of marijuana smoking. Ugeskr Laeger 168(18):1743–1746PubMed
18.
Zurück zum Zitat Kagen SL, Kurup VP, Sohnle PG et al (1983) Marijuana smoking and fungal sensitization. J Allergy Clin Immunol 71(4):389–393PubMedCrossRef Kagen SL, Kurup VP, Sohnle PG et al (1983) Marijuana smoking and fungal sensitization. J Allergy Clin Immunol 71(4):389–393PubMedCrossRef
19.
Zurück zum Zitat Kagen SL (1981) Aspergillus: an inhalable contaminant of marijuana. N Engl J Med 304(8):483–484PubMed Kagen SL (1981) Aspergillus: an inhalable contaminant of marijuana. N Engl J Med 304(8):483–484PubMed
20.
21.
Zurück zum Zitat Centeno-Lima S, de Lacerda JM, do Carmo JA et al (2002) Follow-up of anti-Aspergillus IgG and IgA antibodies in bone marrow transplanted patients with invasive aspergillosis. J Clin Lab Anal 16(3):156–162PubMedCrossRef Centeno-Lima S, de Lacerda JM, do Carmo JA et al (2002) Follow-up of anti-Aspergillus IgG and IgA antibodies in bone marrow transplanted patients with invasive aspergillosis. J Clin Lab Anal 16(3):156–162PubMedCrossRef
22.
Zurück zum Zitat Sole A, Salavert M (2009) Fungal infections after lung transplantation. Curr Opin Pulm Med 15(3):243–253PubMedCrossRef Sole A, Salavert M (2009) Fungal infections after lung transplantation. Curr Opin Pulm Med 15(3):243–253PubMedCrossRef
23.
Zurück zum Zitat Bergeron A, Belle A, Sulahian A et al (2010) Contribution of galactomannan antigen detection in BAL to the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies. Chest 137(2):410–415PubMedCrossRef Bergeron A, Belle A, Sulahian A et al (2010) Contribution of galactomannan antigen detection in BAL to the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies. Chest 137(2):410–415PubMedCrossRef
24.
Zurück zum Zitat Jennings TS, Hardin TC (1993) Treatment of aspergillosis with itraconazole. Ann Pharmacother 27(10):1206–1211PubMed Jennings TS, Hardin TC (1993) Treatment of aspergillosis with itraconazole. Ann Pharmacother 27(10):1206–1211PubMed
25.
Zurück zum Zitat Campbell JH, Winter JH, Richardson MD et al (1991) Treatment of pulmonary aspergilloma with itraconazole. Thorax 46(11):839–841PubMedCrossRef Campbell JH, Winter JH, Richardson MD et al (1991) Treatment of pulmonary aspergilloma with itraconazole. Thorax 46(11):839–841PubMedCrossRef
26.
Zurück zum Zitat De Beule K, De Doncker P, Cauwenbergh G et al (1988) The treatment of aspergillosis and aspergilloma with itraconazole, clinical results of an open international study (1982–1987). Mycoses 31(9):476–485PubMedCrossRef De Beule K, De Doncker P, Cauwenbergh G et al (1988) The treatment of aspergillosis and aspergilloma with itraconazole, clinical results of an open international study (1982–1987). Mycoses 31(9):476–485PubMedCrossRef
27.
Zurück zum Zitat Dupont B (1990) Itraconazole therapy in aspergillosis: study in 49 patients. J Am Acad Dermatol 23(3 Pt 2):607–614PubMedCrossRef Dupont B (1990) Itraconazole therapy in aspergillosis: study in 49 patients. J Am Acad Dermatol 23(3 Pt 2):607–614PubMedCrossRef
28.
Zurück zum Zitat Soltanzadeh H, Wychulis AR, Sadr F et al (1977) Surgical treatment of pulmonary aspergilloma. Ann Surg 186(1):13–16PubMedCrossRef Soltanzadeh H, Wychulis AR, Sadr F et al (1977) Surgical treatment of pulmonary aspergilloma. Ann Surg 186(1):13–16PubMedCrossRef
29.
Zurück zum Zitat Guerra M, Santos N, Miranda J et al (2008) Surgical management of pulmonary aspergilloma. Rev Port Cir Cardiotorac Vasc 15(3):135–138PubMed Guerra M, Santos N, Miranda J et al (2008) Surgical management of pulmonary aspergilloma. Rev Port Cir Cardiotorac Vasc 15(3):135–138PubMed
30.
Zurück zum Zitat Chen JC, Chang YL, Luh SP et al (1997) Surgical treatment for pulmonary aspergilloma: a 28 year experience. Thorax 52(9):810–813PubMedCrossRef Chen JC, Chang YL, Luh SP et al (1997) Surgical treatment for pulmonary aspergilloma: a 28 year experience. Thorax 52(9):810–813PubMedCrossRef
31.
Zurück zum Zitat Brik A, Salem AM, Kamal AR et al (2008) Surgical outcome of pulmonary aspergilloma. Eur J Cardiothorac Surg 34(4):882–885PubMedCrossRef Brik A, Salem AM, Kamal AR et al (2008) Surgical outcome of pulmonary aspergilloma. Eur J Cardiothorac Surg 34(4):882–885PubMedCrossRef
32.
Zurück zum Zitat Caidi M, Kabiri H, Al Aziz S et al (2006) Surgical treatment of pulmonary aspergilloma. 278 cases. Presse Med 35(12 Pt 1):1819–1824PubMedCrossRef Caidi M, Kabiri H, Al Aziz S et al (2006) Surgical treatment of pulmonary aspergilloma. 278 cases. Presse Med 35(12 Pt 1):1819–1824PubMedCrossRef
33.
Zurück zum Zitat Camuset J, Nunes H, Dombret MC et al (2007) Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients. Chest 131(5):1435–1441PubMedCrossRef Camuset J, Nunes H, Dombret MC et al (2007) Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients. Chest 131(5):1435–1441PubMedCrossRef
34.
Zurück zum Zitat Felton TW, Baxter C, Moore CB et al (2010) Efficacy and safety of posaconazole for chronic pulmonary aspergillosis. Clin Infect Dis 51(12):1383–1391PubMedCrossRef Felton TW, Baxter C, Moore CB et al (2010) Efficacy and safety of posaconazole for chronic pulmonary aspergillosis. Clin Infect Dis 51(12):1383–1391PubMedCrossRef
35.
Zurück zum Zitat Lee KS, Kim HT, Kim YH et al (1993) Treatment of hemoptysis in patients with cavitary aspergilloma of the lung: value of percutaneous instillation of amphotericin B. AJR Am J Roentgenol 161(4):727–731PubMed Lee KS, Kim HT, Kim YH et al (1993) Treatment of hemoptysis in patients with cavitary aspergilloma of the lung: value of percutaneous instillation of amphotericin B. AJR Am J Roentgenol 161(4):727–731PubMed
36.
Zurück zum Zitat Rumbak M, Kohler G, Eastrige C et al (1996) Topical treatment of life threatening haemoptysis from aspergillomas. Thorax 51(3):253–255PubMedCrossRef Rumbak M, Kohler G, Eastrige C et al (1996) Topical treatment of life threatening haemoptysis from aspergillomas. Thorax 51(3):253–255PubMedCrossRef
37.
Zurück zum Zitat Kaplan J, Johns CJ (1979) Mycetomas in pulmonary sarcoidosis: non-surgical management. Johns Hopkins Med J 145(4):157–161PubMed Kaplan J, Johns CJ (1979) Mycetomas in pulmonary sarcoidosis: non-surgical management. Johns Hopkins Med J 145(4):157–161PubMed
38.
Zurück zum Zitat Idali F, Wikén M, Wahlström J et al (2006) Reduced Th1 response in the lungs of HLA-DRB1*0301 patients with pulmonary sarcoidosis. Eur Respir J 27(3):451–459PubMedCrossRef Idali F, Wikén M, Wahlström J et al (2006) Reduced Th1 response in the lungs of HLA-DRB1*0301 patients with pulmonary sarcoidosis. Eur Respir J 27(3):451–459PubMedCrossRef
39.
Zurück zum Zitat Chaudhary N, Staab JF, Marr KA (2010) Healthy human T-cell responses to Aspergillus fumigatus antigens. PLoS One 5(2):e9036PubMedCrossRef Chaudhary N, Staab JF, Marr KA (2010) Healthy human T-cell responses to Aspergillus fumigatus antigens. PLoS One 5(2):e9036PubMedCrossRef
40.
Zurück zum Zitat Judson MA (2009) Allergic bronchopulmonary aspergillosis after infliximab therapy for sarcoidosis: a potential mechanism related to T-helper cytokine balance. Chest 135(5):1358–1359PubMedCrossRef Judson MA (2009) Allergic bronchopulmonary aspergillosis after infliximab therapy for sarcoidosis: a potential mechanism related to T-helper cytokine balance. Chest 135(5):1358–1359PubMedCrossRef
Metadaten
Titel
Aspergillus Lung Disease in Patients with Sarcoidosis: A Case Series and Review of the Literature
verfasst von
Tahuanty A. Pena
Ayman O. Soubani
Lobelia Samavati
Publikationsdatum
01.04.2011
Verlag
Springer-Verlag
Erschienen in
Lung / Ausgabe 2/2011
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-011-9280-9

Weitere Artikel der Ausgabe 2/2011

Lung 2/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.